Peptide News
On Oct 28, 2026, Health Secretary Robert F. Kennedy Jr. said HHS won’t take action against licensed pharmacies that compound (custom-mix a drug to fill one patient’s prescription) six unapproved peptides: BPC-157, TB-500, KPV, MOTS-c, Epitalon and Semax. That opens a prescription route, under certain rules. It does not make any of the six FDA-approved….
Oct 22, 2026 · What changed in peptides this week, what it means for you, and what didn’t change. On Oct 14, the FDA sent a plan called the “Interim Access Policy for Compounding Using Certain Peptides” to the White House for review (reginfo.gov). Reports say it would let compounding pharmacies (which custom-mix medicine for…
There are now two FDA-approved weight-loss pills in the GLP-1 family: the Wegovy pill (semaglutide, from Novo Nordisk), approved in December 2025, and Foundayo (orforglipron, from Eli Lilly), approved in April 2026. Both are once-a-day tablets that act on the same appetite hormone as the weekly shots. GLP-1 is a hormone your gut releases after…
The FDA has received two reports of people dying after taking products sold online as retatrutide, an experimental weight-loss drug from Eli Lilly that isn’t approved for anyone to use outside clinical trials. These reports haven’t been verified, and on their own they can’t show the product caused either death — but they’re the first…
Oct 8, 2026 · What changed in peptides this week, what it means for you, and what didn’t change. The Washington Post reported on Oct 7 that the Trump administration is drawing up a plan to let compounding pharmacies (pharmacies that mix custom medicines for individual prescriptions) temporarily sell certain restricted peptides while federal officials…
Peptide Sciences shut down on March 6, 2026. It was one of the biggest online sellers of “research use only” peptides, meaning products sold with no prescription, no medical oversight, and no guarantee of what’s in the vial. The company says it closed voluntarily. It hasn’t said why, so every reason you’ve seen online is…
October 1, 2026 · What changed in peptides this week, what it means for you, and what didn’t change. In a large trial published this week, Eli Lilly’s experimental weight-loss drug retatrutide helped people with type 2 diabetes lose about a fifth of their body weight. It still isn’t FDA-approved, and Lilly says it won’t…